Saturday, November 27, 2021

Omicron variant sets off renewed Covid hysteria

Headline courtesy CNN News, Nov. 27, 2021.

Are We Overreacting to Omicron? | Brownstone Institute - Dr. Paul Elias Alexander:

November 26, 2021 - "With natural exposure immunity and early outpatient treatment and when combined with no reports of increased lethality, the WHO’s reaction of generating panic toward 'Omicron' is causing needless fear.... So too with the Biden administration’s newly imposed travel restrictions, which will achieve nothing and will once again disrupt trade and violate human rights. 

"The WHO has said that the Omicron variant can spread more quickly than other variants. Likely true. The virus is behaving just like how viruses behave. They are mutable and mutate and via Muller’s ratchet, we expect this to be milder and milder mutations and not more lethal ones.... The virus will mutate downward so that it can use the host (us) to propagate itself via our cellular metabolic machinery. The Delta has shown us this: it is very infectious and mostly non-lethal. Especially for children and healthy people. So is the WHO panicking the globe needlessly? Is this Covid-19 February 2020 once again? 

"The problem with South Africa as is with Australia and New Zealand and even island nations like Trinidad is ... low natural immunity to SAR-Cov-2. This is because, as we witnessed over the last year and more, if you lock down your society too long and too hard, you deny the nation and population from inching closer to population-level herd immunity. And you have no economy or society [into] which to  reemerge. You devastate your society for a pathogen that is largely harmless to the vast majority of people especially children.... 

"These nations thought that they could stay locked down and wait for a vaccine. This is a reasonable view though I was against lockdowns as they would and did cause crushing harms on especially poor persons and children. The problem is there was an opportunity cost because the vaccine we were waiting on was suboptimally developed without the proper safety testing or assessment of effectiveness. 

"We have data that the Pfizer vaccine loses 40% of antibodies per month, meaning in 3 months post-shot, you have low effective vaccinal immunity.... For example, the vaccine has failed to stop infection and spread against Delta. We have research findings by Singanayagam et al. (fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts), by Chau et al. (viral loads of breakthrough Delta variant infection cases in vaccinated nurses were 251 times higher than those of cases infected with prior strains early 2020), and by Riemersma et al. (no difference in viral loads when comparing unvaccinated individuals to those who have vaccine 'breakthrough' infections and if vaccinated individuals become infected with the delta variant, they may be sources of SARS-CoV-2 transmission to others) that reveal the vaccines have very suboptimal efficacy. 

"This situation of the vaccinated being infectious and transmitting the virus has also emerged in seminal nosocomial outbreak papers by Chau et al. (HCWs in Vietnam), the Finland hospital outbreak (spread among HCWs and patients), and the Israel hospital outbreak (spread among HCWs and patients). These studies have also revealed that the PPE and masking were essentially ineffective within the healthcare setting. All of the HCWs were double-vaccinated yet there was extensive spread to themselves and their patients. 

"In addition, Nordström et al. (vaccine effectiveness of Pfizer against infection waned progressively from 92% day 15-30 to 47% day 121-180, and from day 211 and onwards no effectiveness), Suthar et al. (a substantial waning of antibody responses and T cell immunity to SARS-CoV-2 and its variants, at 6 months following the second immunization), Yahi et al. (with Delta variant, neutralizing antibodies have a decreased affinity for the spike protein, whereas facilitating antibodies display a strikingly increased affinity), Juthani et al. (higher numbers of patients with severe or critical illness in those who received the Pfizer vaccine), Gazit et al. (SARS-CoV-2-naïve vaccinees had a 13-fold increased risk for breakthrough infection with the Delta variant, and substantially elevated risk of symptomatic Covid and hospitalization), and Acharya et al. (no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with Delta) collectively reveal the poor efficacy and even negative efficacy of the Covid vaccines. Levine-Tiefenbrun et al. reports that the viral load reduction effectiveness declines with time after vaccination, 'significantly decreasing at 3 months after vaccination and effectively vanishing after about 6 months.'

"As an example, the Swedish study (retrospective with 842,974 pairs (N=1,684,958) is particularly alarming for it shows that while the vaccine provides temporary protection against infection, the efficacy declines below zero and then to negative efficacy territory at approximately 7 months, underscoring that the vaccinated are highly susceptible to infection and eventually become highly infected (more so than the unvaccinated). A further example emerges from Ireland whereby reporting suggests that the Waterford city district has the State’s highest rate of Covid-19 infections, while the county also boasts the highest rate of vaccination in the Republic (99.7% vaccinated). Reports are that the U.S. Covid-19 deaths for 2021 surpassed the deaths from 2020, leading some to state that 'more people have died from COVID-19 in 2021, with most adults vaccinated and nearly all seniors), than in 2020 when nobody was vaccinated.' 

"Thus these nations that locked down and stayed that way are in a quandary for they do not know what to do now. If you open you will get surges in infection. Where is the money that was to go to hospital preparation?....

"We have a lot of natural immunity in the US, e.g. near 65-70% of the population. The open states (those that did not lock down too long and too hard and opened quickly) will likely do very well with this Omicron or any new variant. This also is the power of natural immunity. And we need not forget the potency of the overlooked ‘innate’ immunity with the innate antibodies and innate natural killer cellular compartment. This innate response is particularly potent in children (our first line of defense against pathogens) and is what has spared children from Covid and how children typically stave off pathogens, especially young children still laying down immunological memory. 

"Moreover, there is no reporting of increased virulence/lethality of this new Omicron variant. As yet this will remain the case based on Delta and prior variants. There are no guarantees but we operate based on risk and all things point to the same for this new variant. Just because there is a wave in SA does not mean that there will be waves in the US or Israel or other places with greater natural immunity. This was the prize of letting people enjoy day-to-day living. The nations that have ended lockdowns are likely to move past this new variant scare.... This is more of an overreaction by the WHO and governments and much ado about nothing."

Read more: https://brownstone.org/articles/are-we-overreacting-to-omicron/ 

Dr Alexander ... PhD. ... has experience in epidemiology and in the teaching [of] clinical epidemiology, evidence-based medicine, and research methodology. Dr Alexander is a former Assistant Professor at McMaster University in evidence-based medicine and research methods; former COVID Pandemic evidence-synthesis consultant advisor to WHO-PAHO Washington, DC (2020) and former senior advisor to COVID Pandemic policy in Health and Human Services (HHS) Washington, DC (A Secretary), ... currently a COVID-19 consultant researcher in the US-C19 research group.


This work is licensed under a Creative Commons Attribution 4.0 International License.

No comments:

Post a Comment